Overview of Dr. Clerkin
Dr. Kevin Clerkin is a cardiologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from Albert Einstein College of Medicine of Yeshiva University and has been in practice 6 years. He is one of 692 doctors at New York-Presbyterian Hospital and one of 324 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Cardiology. He has more than 100 publications and over 500 citings.
Office
622 W 168th St
New York, NY 10032Fax+1 212-305-7439
Education & Training
- New York Presbyterian Hospital (Columbia Campus)Fellowship, Advanced Heart Failure and Transplant Cardiology, 2018 - 2019
- New York Presbyterian Hospital (Columbia Campus)Fellowship, Cardiovascular Disease, 2014 - 2018
- Columbia UniversityMSc, Biostatistics, 2015 - 2017
- New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 2011 - 2014
- Albert Einstein College of MedicineClass of 2011
Certifications & Licensure
- CT State Medical License 2019 - 2026
- NY State Medical License 2013 - 2026
- NJ State Medical License 2023 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
- American Board of Internal Medicine Cardiovascular Disease
- National Board of EchocardiographyComprehensive
Awards, Honors, & Recognition
- Inductee Alpha Omega Alpha Honor Medical Society, 2011
Publications & Presentations
PubMed
- Can Grading of Mild Cardiac Allograft Vasculopathy be Further Refined? An angiographic and physiologic assessment of heart transplant recipients with ISHLT CAV 1.Nikil Prasad, Erin Harris, Melana Yuzefpolskaya, Ersilia M DeFilippis, Paolo C Colombo
The Journal of Heart and Lung Transplantation. 2024-12-30 - The waiting is the hardest part.Kevin J Clerkin, Nir Uriel
The Journal of Heart and Lung Transplantation. 2024-12-18 - Elevated Donor-Derived Cell-Free DNA Levels Are Associated With Reduced Myocardial Blood Flow but Not Angiographic Cardiac Allograft Vasculopathy: The EVIDENT Study.Cathrine M Moeller, Daniel Oren, Andrea Fernandez Valledor, Gal Rubinstein, Ersilia M DeFilippis
Circulation. Heart Failure. 2024-12-10
Journal Articles
- Characteristics and Outcomes of Recipients of Heart Transplant with Coronavirus Disease 2019Farhana Latif, Maryjane A Farr, Kevin J Clerkin, Koji Takeda, Yoshifumi Naka, Susan Restaino, Gabriel Sayer, Nir Uriel, JAMA Cardiology
Authored Content
- Characteristics and Outcomes of Recipients of Heart Transplant with Coronavirus Disease 2019May 2020
- Characteristics and Outcomes of Recipients of Heart Transplant with Coronavirus Disease 2019May 2020
Press Mentions
- Study Affirms Higher CVD, Mortality Risks Among COVID-Positive PatientsOctober 26th, 2022
- Coronary and Cerebral Thrombosis in a Young Patient After Mild COVID-19 Illness: A Case ReportOctober 1st, 2020
- Cardiac Symptoms Can Be First Sign of COVID-19March 26th, 2020
- Join now to see all
Grant Support
- Identifying Novel Diagnostics and Mechanisms for Cardiac Allograft VasculopathyNATIONAL HEART, LUNG, AND BLOOD INSTITUTEPresent
Professional Memberships
- Fellow
- Fellow
- International Society for Heart and Lung TransplantationMember
External Links
- Columbia Profilehttps://www.columbiacardiology.org/profile/kevin-j-clerkin-md
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: